In this episode, join the conversation with Dr. E.F.RAIN and Dr. Sarah Hägg, an associate professor in molecular epidemiology at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet. They delve into recent results of a study showing that some antidiabetic drugs could have a potential protective effect against Alzheimer's disease.
This conversation was based on the following article:
Reference: Tang B, Wang Y, Jiang X, Thambisetty M, Ferrucci L, Johnell K, Hägg S. Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study. Neurology. 2022 Aug 16;99(7):e650-e659. doi: 10.1212/WNL.0000000000200771. Epub 2022 Jun 2. PMID: 35654594; PMCID: PMC9484609.
Follow us on social media!
-Instagram and TikTok: @agora_health
-Facebook Page: Agora Health
-Spotify, Apple Podcasts and Amazon Music: Decoding Healthcare Research
- Dr.E.F.Rain as @dr.ef.rain on Instagram.
Disclosure:
The content of this podcast is purely academic in nature and is intended for educational and informational purposes only. The material discussed does not represent or reflect the views, opinions, or policies of the Medical College of Georgia, and the information presented should not be construed as medical advice or guidance. Always consult with a qualified healthcare professional for any medical concerns or questions. I'd like to explicitly state that I have no endorsement from, affiliations with, or financial interests in any pharmaceutical companies or medical device manufacturers. Any mention of medications, devices, or treatments is made solely within the context of literature and academic discussion.
